Speaker illustration

Associate Professor Qingjie Li

University of Texas Medical Branch , Galveston (United States of America)

Member of:

European Society of Cardiology

Dr. Li is an Associate Professor at the Division of Gastroenterology, Department of Internal Medicine, University of Texas Medical Branch at Galveston. He earned his master’s Degree in Organic Chemistry in 1991 and his PhD degree in Biochemistry and Molecular Biology in 2000. He received his postdoctoral training at the Linus Pauling Institute, Oregon State University, where he worked on molecular mechanisms and chemoprevention of colorectal cancer. Dr. Li’s research interests lie in inflammatory bowel disease (IBD), a complex GI disease associated with lifelong medical attention, poor quality of life and huge economic burden, as well as in IBD-associated disorders, including colitis-associated cancer and IBD-induced cardiovascular diseases. Dr. Li has been very well funded by NIH, the Crohn’s & Colitis Foundation of America, and the American Heart Association for research in gastrointestinal and cardiovascular science.

Dysbiotic microbiome induce cardiac impairment by attenuating brain-derived neurotrophic factor in inflammatory bowel diseases

Event: ESC Congress 2023

Topic: Leukocytes, Inflammation, Immunity

Session: Metabolism and cardiac disease

Thumbnail

Experimental colitis impedes cardiac function through epigenetic mechanisms

Event: ESC Congress 2018

Topic: Genetics, Epigenetics, ncRNA

Session: Cardiac biology - Heart failure

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb